GlassScriptPhysician profile
Cheri Daniels
NPI 1952436347
$1,762.87
in general payments reported to CMS, 2019-2025
22 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $362 · 2022: $787 · 2023: $156 · 2024: $224 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $270.34 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $186.59 | 2022-2024 | Jornay Pm |
| Myovant Sciences INC. | $180.15 | 2021-2022 | |
| Astellas Pharma US INC | $130.29 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $100.03 | 2025 | Jornay Pm |
| Olympus America INC. | $99.61 | 2022 | |
| Urovant Sciences INC | $99.26 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.48 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $65.60 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $64.48 | 2022 | |
| Abbvie INC. | $63.53 | 2022-2024 | |
| Dentsply Ih INC. | $58.09 | 2021-2022 | |
| Amgen INC. | $57.31 | 2022-2023 | Xgeva |
| Antares Pharma, INC. | $52.67 | 2022 | |
| Coloplast Corp | $48.70 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $45.25 | 2025 | Bexsero |
| Astrazeneca Pharmaceuticals LP | $42.58 | 2021-2022 | |
| Axonics, INC. | $37.62 | 2022 | |
| Supernus Pharmaceuticals, INC. | $22.17 | 2022 | |
| Blue Earth Diagnostics | $16.09 | 2021 | |
| Merck Sharp & Dohme LLC | $15.02 | 2021 | |
| Pfizer INC. | $12.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheri Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.